125 related articles for article (PubMed ID: 6247783)
1. Effects of 2-nicotinamidethyl nitrate (SG-75), a new antianginal drug, on the cyclic AMP phosphodiesterase activity.
Endoh M; Yanagisawa T; Taira N
Tohoku J Exp Med; 1980 Feb; 130(2):199-201. PubMed ID: 6247783
[TBL] [Abstract][Full Text] [Related]
2. Potentiating effect of nicorandil, an antianginal agent, on relaxation induced by isoproterenol in isolated rat aorta: involvement of cyclic GMP-inhibitable cyclic AMP phosphodiesterase.
Satake N; Zhou Q; Morikawa M; Inoue M; Shibata S
J Cardiovasc Pharmacol; 1995 Mar; 25(3):489-94. PubMed ID: 7769818
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro.
Shimoyama M; Kawai M; Nasu S; Shioji K; Hoshi Y
Physiol Chem Phys; 1975; 7(2):125-32. PubMed ID: 239431
[TBL] [Abstract][Full Text] [Related]
4. Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog. Increase in potassium conductance.
Yanagisawa T; Taira N
Naunyn Schmiedebergs Arch Pharmacol; 1980 May; 312(1):69-76. PubMed ID: 6446686
[No Abstract] [Full Text] [Related]
5. Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator.
Sakamoto N; Terai M; Takenaka T; Maeno H
Biochem Pharmacol; 1978; 27(8):1269-74. PubMed ID: 81059
[No Abstract] [Full Text] [Related]
6. Effects of 2-nicotinamidethyl nitrate (SG-75) and/or nitroglycerin on systemic hemodynamics and coronary blood flow in conscious dogs.
Mizukami M; Tomoike H; Inouh T; Watanabe K; Kikuchi Y; Nakamura M
Arzneimittelforschung; 1981; 31(8):1244-7. PubMed ID: 6457606
[TBL] [Abstract][Full Text] [Related]
7. Effect of 2-nicotinamidethyl nitrate (SG-75) on membrane potentials of canine Purkinje fibers.
Yanagisawa T; Taira N
Jpn J Pharmacol; 1981 Jun; 31(3):409-17. PubMed ID: 6458721
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
Ahluwalia GS; Rhoads AR
Biochem Pharmacol; 1982 Mar; 31(5):665-9. PubMed ID: 6177320
[TBL] [Abstract][Full Text] [Related]
9. Effect of 2-nicotinamidethyl nitrate (SG 75) on coronary circulation.
Uchida Y; Yoshimoto N; Murao S
Jpn Heart J; 1978 Jan; 19(1):112-24. PubMed ID: 148520
[TBL] [Abstract][Full Text] [Related]
10. Effects of N-(2-hydroxyethyl)nicotinamide nitrate (SG-75) on methacholine-induced ECG changes in intact anesthetized rats.
Aono J; Akima M; Sakai K
Jpn J Pharmacol; 1981 Oct; 31(5):823-30. PubMed ID: 6458723
[TBL] [Abstract][Full Text] [Related]
11. Effects of a new coronary vasodilator, N-(2-hydroxyethyl)nicotinamide nitrate (SG-75) and nitroglycerin on cardiovascular hemodynamics in young and aged beagle dogs.
Sakai K; Aono J; Haruta K
Jpn J Pharmacol; 1981 Apr; 31(2):281-5. PubMed ID: 6458720
[No Abstract] [Full Text] [Related]
12. Inhibition of calmodulin dependent c-AMP-phosphodiesterase by moxaverine and papaverine.
Mannhold R
Arzneimittelforschung; 1988 Dec; 38(12):1806-8. PubMed ID: 2854468
[TBL] [Abstract][Full Text] [Related]
13. The effects of dilazep and SG 75 on cyclic nucleotides in the coronary artery.
Kobayashi A; Ogawa K; Yamazaki N
Jpn Heart J; 1980 Jan; 21(1):85-94. PubMed ID: 6245291
[TBL] [Abstract][Full Text] [Related]
14. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters.
Greenberg SS; Cantor E; Ho E; Walega M
J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of a new coronary vasodilator N-(2-hydroxyethyl)nicotinamide nitrate (SG-75): comparison with nitroglycerin and diltiazem.
Sakai K; Shiraki Y; Nabata H
J Cardiovasc Pharmacol; 1981; 3(1):139-50. PubMed ID: 6160343
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
Ilien B; Ruckstuhl M; Landry Y
J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
[TBL] [Abstract][Full Text] [Related]
17. Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: an overview.
Taira N
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S1-9. PubMed ID: 2447414
[TBL] [Abstract][Full Text] [Related]
18. Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and cyclic GMP phosphodiesterases.
Miyamoto M; Takayanagi I; Ohkubo H; Takagi K
Jpn J Pharmacol; 1976 Feb; (1):114-7. PubMed ID: 177797
[No Abstract] [Full Text] [Related]
19. Cardiohaemodynamic effects of long-term intravenous administration of N-(2-hydroxyethyl)nicotinamide nitrate (SG-75), a potent coronary vasodilator: comparison with glyceryl trinitrate.
Sakai K; Shiraki Y; Yamazaki T; Akima M; Nabata H; Ohba Y
Clin Exp Pharmacol Physiol; 1981; 8(6):557-65. PubMed ID: 6460572
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic and metabolism studies on a new coronary vasodilator, N-(2-hydroxyethyl) nicotinamide nitrate (SG-75).
Sakai K; Ohba Y; Akima M; Kamiyama H; Hinohara Y; Nakano H
Jpn J Pharmacol; 1980 Dec; 30(6):881-90. PubMed ID: 6454019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
